1. Home
  2. COCP vs GNS Comparison

COCP vs GNS Comparison

Compare COCP & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • GNS
  • Stock Information
  • Founded
  • COCP N/A
  • GNS 2002
  • Country
  • COCP United States
  • GNS Singapore
  • Employees
  • COCP N/A
  • GNS N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • GNS Other Consumer Services
  • Sector
  • COCP Health Care
  • GNS Real Estate
  • Exchange
  • COCP Nasdaq
  • GNS Nasdaq
  • Market Cap
  • COCP 18.3M
  • GNS 15.9M
  • IPO Year
  • COCP N/A
  • GNS 2022
  • Fundamental
  • Price
  • COCP $2.15
  • GNS $0.85
  • Analyst Decision
  • COCP Strong Buy
  • GNS
  • Analyst Count
  • COCP 1
  • GNS 0
  • Target Price
  • COCP $7.00
  • GNS N/A
  • AVG Volume (30 Days)
  • COCP 22.2K
  • GNS 10.7M
  • Earning Date
  • COCP 11-13-2024
  • GNS 11-26-2024
  • Dividend Yield
  • COCP N/A
  • GNS N/A
  • EPS Growth
  • COCP N/A
  • GNS N/A
  • EPS
  • COCP N/A
  • GNS N/A
  • Revenue
  • COCP N/A
  • GNS $23,062,754.00
  • Revenue This Year
  • COCP N/A
  • GNS $39.87
  • Revenue Next Year
  • COCP N/A
  • GNS $32.96
  • P/E Ratio
  • COCP N/A
  • GNS N/A
  • Revenue Growth
  • COCP N/A
  • GNS 26.76
  • 52 Week Low
  • COCP $1.33
  • GNS $0.51
  • 52 Week High
  • COCP $3.10
  • GNS $9.49
  • Technical
  • Relative Strength Index (RSI)
  • COCP 64.04
  • GNS 55.70
  • Support Level
  • COCP $1.65
  • GNS $0.79
  • Resistance Level
  • COCP $1.82
  • GNS $1.50
  • Average True Range (ATR)
  • COCP 0.17
  • GNS 0.18
  • MACD
  • COCP 0.03
  • GNS 0.04
  • Stochastic Oscillator
  • COCP 64.10
  • GNS 34.97

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.

Share on Social Networks: